Timelo Investment Management Inc. lessened its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 19.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 63,000 shares of the company's stock after selling 15,000 shares during the period. Nutrien accounts for approximately 2.0% of Timelo Investment Management Inc.'s investment portfolio, making the stock its 6th biggest holding. Timelo Investment Management Inc.'s holdings in Nutrien were worth $2,819,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in NTR. Fairway Wealth LLC acquired a new stake in shares of Nutrien in the 4th quarter valued at about $27,000. HHM Wealth Advisors LLC lifted its stake in Nutrien by 331.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company's stock valued at $28,000 after buying an additional 480 shares during the last quarter. Assetmark Inc. increased its holdings in shares of Nutrien by 1,437.5% in the 4th quarter. Assetmark Inc. now owns 738 shares of the company's stock valued at $33,000 after acquiring an additional 690 shares during the period. Asset Planning Inc purchased a new stake in Nutrien in the 4th quarter valued at $35,000. Finally, Exchange Traded Concepts LLC boosted its stake in Nutrien by 96.7% during the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company's stock worth $38,000 after purchasing an additional 416 shares during the period. Hedge funds and other institutional investors own 63.10% of the company's stock.
Nutrien Price Performance
Shares of NTR stock traded up $0.11 during mid-day trading on Friday, reaching $53.79. The stock had a trading volume of 1,180,344 shares, compared to its average volume of 2,090,525. The company has a market cap of $26.29 billion, a P/E ratio of 39.26, a price-to-earnings-growth ratio of 1.19 and a beta of 0.77. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a 12-month low of $43.70 and a 12-month high of $60.87. The business has a 50-day simple moving average of $51.07 and a 200 day simple moving average of $49.36.
Nutrien (NYSE:NTR - Get Free Report) last posted its earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The business had revenue of $5.08 billion for the quarter, compared to analysts' expectations of $5.09 billion. On average, sell-side analysts anticipate that Nutrien Ltd. will post 3.72 earnings per share for the current year.
Nutrien Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, April 10th. Shareholders of record on Monday, March 31st were issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date of this dividend was Monday, March 31st. Nutrien's dividend payout ratio (DPR) is presently 159.12%.
Analyst Ratings Changes
A number of equities research analysts have recently commented on NTR shares. The Goldman Sachs Group assumed coverage on shares of Nutrien in a report on Thursday, March 13th. They issued a "sell" rating and a $53.00 target price for the company. Royal Bank of Canada reaffirmed an "outperform" rating and set a $60.00 price objective on shares of Nutrien in a research report on Monday, February 24th. Barclays boosted their target price on Nutrien from $56.00 to $59.00 and gave the company an "equal weight" rating in a report on Wednesday, March 5th. UBS Group decreased their price target on Nutrien from $54.00 to $52.00 and set a "neutral" rating for the company in a report on Wednesday, April 16th. Finally, Mizuho boosted their price objective on shares of Nutrien from $52.00 to $55.00 and gave the company a "neutral" rating in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $59.27.
Get Our Latest Stock Analysis on NTR
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Further Reading

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.